
Thu Sep 26 14:12:04 UTC 2024: ## Jaguar Health Focuses on Improving Cancer Patient Quality of Life with New Survey
**SAN FRANCISCO, CA – September 26, 2024** – Jaguar Health, Inc. (NASDAQ:JAGX) announced that Stacey Tinianov, MPH, founder of Advocates for Collaborative Education (ACE) and a member of Jaguar’s Scientific Advisory Board, will present a poster on September 27th at the American Society of Clinical Oncology (ASCO) Quality Care Symposium.
The poster, titled “Measuring what really matters: Advocacy-led co-creation and accrual of a pan-cancer QoL survey,” will highlight the methodologies used to design and execute the “More Than a Diagnosis: A Quality of Life Survey for Individuals with a Diagnosis or History of Cancer.” This survey, sponsored by Jaguar’s family company Napo Pharmaceuticals, is designed to understand the specific challenges faced by cancer patients and survivors.
Tinianov emphasizes the need for better tools to assess the quality of life (QoL) of cancer patients and survivors, as currently used methods often fail to capture their most pressing concerns. The “More Than a Diagnosis” survey aims to address this gap by focusing on the challenges that truly impact patients’ lives.
This initiative highlights Jaguar Health’s commitment to supportive care for cancer patients, focusing on improving their quality of life by addressing unmet needs. The company hopes that the insights gained from the survey will guide improvements in supportive care and lead to better outcomes for cancer patients and survivors.